HIV & aging
The advancement of exceptionally dynamic hostile to retroviral treatment (HAART) for HIV contamination in the 1990s is one of present day drug's most sensational examples of overcoming adversity. Once successfully a capital punishment, HIV disease can now be viewed as a genuine, yet to a great extent sensible, interminable condition. Today, a man who starts HAART can sensibly hope to experience another 30 to 50 years and regularly well into more seasoned age. In any case, large portions of the medications used to treat HIV have not been around for long. While transient reactions are very much inquired about and reported, longer-term symptoms are less surely knew. Some HIV drugs influence the kidneys, liver, bones and heart in unpretentious ways. As a major aspect of your normal wellbeing checking, your medicinal services proficient will watch out for how well your body is functioning, so any issues can be distinguished and treated early.
- Systems biology in HIV, METH and cART
- HIV- diagnosis, retroviral transmission and prevention
- Mother-to-child transmission of HIV
- Social, cultural, economic and political issues of sexuality
- Opportunistic diseases in HIV
Related Conference of HIV & aging
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
HIV & aging Conference Speakers
Recommended Sessions
- Advanced Techniques involved in STDs
- AIDS stigma and discrimination
- Emerging Technologies towards HIV/AIDS
- Global Epidemiology of HIV/AIDS, STDs, & STIs
- HIV & aging
- HIV in women
- HIV Infection
- HIV Prevention, Treatment & Cure
- HIV Related Infections, Co-Infections and Cancers
- HIV/AIDS, STDs & STIs
- Immunology of HIV/AIDS, STDs & STIs
- knowledge on HIV/AIDS, STDs and STIs
- Lived experience of HIV
- Outbreaks- HIV/AIDS, STDs & STIs
- STD symptoms
- Vaccine Development
- Viral, Bacterial, Fungal & Protozoan STDs
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)